Aptinyx


Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system, starting with painful diabetic neuropathy, fibromyalgia, PTSD, and Parkinson’s cognitive impairment.

Industries

Employees

51-200

Links


Org chart

M. Amin Khan
VP, Chemistry R&D
Mary Suh-Butler
Associate Director Clinical Safety
Peter N. Chresanthakes
Director Of Financial Reporting And Accounting

Board & advisors

Gerard Sanacora
Scientific Advisor
Peter Lewitt
Scientific Advisor
Lesley Arnold
Scientific Advisor
Chadi Abdallah
Scientific Advisor


Offices